NDC 68788-7611 Clear Eyes Redness Relief

Naphazoline Hydrochloride And Glycerin

NDC Product Code 68788-7611

NDC CODE: 68788-7611

Proprietary Name: Clear Eyes Redness Relief What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.

Non-Proprietary Name: Naphazoline Hydrochloride And Glycerin What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

Drug Use Information

Drug Use Information
The drug use information is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate. This information is not individual medical advice and does not substitute for the advice of a health care professional. Always ask a health care professional for complete information about this product and your specific health needs.

  • This product is used to relieve occasional constipation. Glycerin belongs to a class of drugs known as hyperosmotic laxatives. It works by drawing water into the intestines. This effect usually results in a bowel movement within 15 to 60 minutes. For adults, the normal frequency of bowel movements varies from once daily to 1 to 2 times weekly. For preschool-aged children, the normal frequency of bowel movements varies from once daily to once every other day. Constipation is best treated by drinking plenty of fluids, eating foods high in fiber, and exercising regularly.

NDC Code Structure

  • 68788 - Preferred Pharmaceuticals Inc.

NDC 68788-7611-1

Package Description: 1 BOTTLE in 1 BOX > 30 mL in 1 BOTTLE

NDC Product Information

Clear Eyes Redness Relief with NDC 68788-7611 is a a human over the counter drug product labeled by Preferred Pharmaceuticals Inc.. The generic name of Clear Eyes Redness Relief is naphazoline hydrochloride and glycerin. The product's dosage form is liquid and is administered via ophthalmic form.

Labeler Name: Preferred Pharmaceuticals Inc.

Dosage Form: Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Clear Eyes Redness Relief Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

  • NAPHAZOLINE HYDROCHLORIDE .12 mg/mL
  • GLYCERIN 2.5 mg/mL

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)
  • BORIC ACID (UNII: R57ZHV85D4)
  • EDETATE DISODIUM (UNII: 7FLD91C86K)
  • WATER (UNII: 059QF0KO0R)
  • SODIUM BORATE (UNII: 91MBZ8H3QO)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Ophthalmic - Administration to the external eye.
  • Ophthalmic - Administration to the external eye.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Preferred Pharmaceuticals Inc.
Labeler Code: 68788
FDA Application Number: part349 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 02-07-2020 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2021 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.

* Please review the disclaimer below.

Clear Eyes Redness Relief Product Label Images

Clear Eyes Redness Relief Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Other

Clear Eyes Redness ReliefDrug Facts

Clear Eyes Redness Relief, Handy Pocket Pal Drug Facts

Active Ingredients

Glycerin 0.25%

Naphazoline hydrochloride 0.012%

Glycerin 0.25%

Naphazoline hydrochloride 0.012%

Purpose

Lubricant

Redness Reliever

Lubricant

Redness Reliever

Uses

  • •relieves redness of the eye due to minor eye irritations •for use as a protectant against further irritation or to relieve dryness of the eye •for the temporary relief of burning and irritation due to dryness of the eye

  • •Relieves redness of the eye due to minor eye irritations. •For use as a protectant against further irritation or to relieve dryness of the eye. •Temporarily relieves burning and irritation due to dryness of the eye.

Warnings

For external use only

For external use only

Do Not Use

If solution changes color or becomes cloudy

If solution changes color or becomes cloudy.

Ask A Doctor Before Use If

You have narrow angle glaucoma.

You have narrow angle glaucoma.

When Using This Product:

  • •pupils may become enlarged temporarily •overuse may produce increased redness of the eye •remove contact lenses before using •to avoid contamination, do not touch tip of container to any surface •replace cap after using

Stop Use And Ask A Doctor If

  • •you experience eye pain •you experience changes in vision •you experience continued redness or irritation of the eye •the condition worsens •symptoms last for more than 72 hours

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

If swallowed, get medical help or contact a Poison Control Center  (1-800-222-1222) right away.

Directions

Instill 1 to 2 drops in the affected eye(s) up to 4 times daily.

Instill 1 to 2 drops in the affected eye(s) up to four times daily.

Other Information

  • •store at room temperature •

  • •Store Between 20° -25°C (68° -77°F) •Remove contact lenses before using. Relabeled By: Preferred Pharmaceuticals Inc.

Inactive Ingredients

Benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate

Benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate

Questions?

1-877-274-1787 www.cleareyes.com.

1-877-274-1787 www.cleareyes.com

When Using This Product

  • •To avoid contamination, do not touch tip to any surface. •Replace cap after using. •Overuse may cause increased redness of the eye. •Pupils may become enlarged temporarily.

Stop Use & Ask A Doctor If

  • •you experience eye pain •you experience changes in vision •you experience continued redness or irritation of the eye •the condition worsens •symptoms last for more than 72 hours

* Please review the disclaimer below.